REAL-WORLD COMPARISON OF HEALTH CARE UTILIZATION BETWEEN DULOXETINE INITIATORS AND PREGABALIN INITIATORS AMONG FIBROMYALGIA PATIENTS

被引：0
|
作者：
Peng, X. [1 ]
Sun, P. [2 ]
Wu, A. [3 ]
Andrews, J. S. [1 ]
Novick, D. [4 ]
Faries, D. [1 ]
Sun, S. [5 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Kailo Res Grp, Fishers, IN USA
[3] Kailo Res Grp, Los Angeles, CA USA
[4] Eli Lilly & Co, Windlesham, Surrey, England
[5] Kailo Res Grp, Fremont, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1432
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A453 / A454
页数：2
相关论文
共 50 条
  • [41] REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTIN
    Udall, M.
    Mardekian, J.
    Harnett, J.
    VALUE IN HEALTH, 2011, 14 (03) : A64 - A64
  • [42] DOSING PROFILE COMPARISON BETWEEN PATIENTS WITH FIBROMYALGIA INITIATING DULOXETINE AND PREGABALIN IN 2007: A LARGE NATIONAL RETROSPECTIVE COHORT STUDY
    Sun, P.
    Zhao, Y.
    Wu, A.
    Sun, S.
    VALUE IN HEALTH, 2010, 13 (07) : A311 - A311
  • [43] Potential Drug-Drug and Drug-Condition Interactions among Fibromyalgia Patients Initiating Pregabalin or Duloxetine: Prevalence and Health Care Expenditure Impact
    Johnston, Stephen S.
    Udall, Margarita
    Cappelleri, Joseph C.
    Johnson, Barbara H.
    Shrady, George
    Chu, Bong-Chul
    Silverman, Stuart L.
    PAIN MEDICINE, 2014, 15 (08) : 1282 - 1293
  • [44] Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin
    Tepper, P.
    Mardekian, J.
    Masseria, C.
    Phatak, H.
    Kamble, S.
    Abdulsattar, Y.
    Petkun, W.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 339 - 339
  • [45] Patient characteristics of new initiators of glycopyrronium bromide (GLY) - A multinational, multi-database real-world drug-utilization study
    Verhamme, Katia M. C.
    De Ridder, Maria
    Pedersen, Lars
    Prieto-Alhambra, Daniel
    Lapi, Francesco
    Rijnbeek, Peter
    Amar, Rajeev K.
    Sturkenboom, Miriam
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [46] Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost
    Harrington, Josephine
    Kang, Yu Mi
    McGuire, Darren K.
    DIABETES CARE, 2024, 47 (11) : 1897 - 1899
  • [47] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [48] Real-World Utilization of Midostaurin Among Patients with Systemic Mastocytosis (SM)
    Gajra, Ajeet
    Klink, Andrew J.
    Chopra, Dhruv
    Feinberg, Bruce
    BLOOD, 2019, 134
  • [49] Real-World Utilization of Istradefylline Among Patients with Parkinson's Disease
    Rezak, M.
    Qian, J.
    Zhao, Y.
    Silverstein, A.
    Chamber, J.
    Swindle, J.
    Kronfeld, N.
    LeWitt, P.
    MOVEMENT DISORDERS, 2023, 38 : S622 - S622
  • [50] Real-world cancer care utilization among patients with breast cancer with germline variants of uncertain significance
    Kurian, Allison W.
    Hughes, Kevin S.
    Young, Sarah M. Nielsen
    Russell, Emily M.
    Facio, Flavia
    Moretz, Chad
    Ellsworth, Rachel
    Alvarez, Daniel Esteban Pineda
    Esplin, Ed
    Korn, W. Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345